KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Retained Earnings (2016 - 2025)

Pacific Biosciences Of California has reported Retained Earnings over the past 16 years, most recently at $457000.0 for Q4 2025.

  • Quarterly results put Retained Earnings at $457000.0 for Q4 2025, up 8.29% from a year ago — trailing twelve months through Dec 2025 was $457000.0 (up 8.29% YoY), and the annual figure for FY2025 was $457000.0, up 8.29%.
  • Retained Earnings for Q4 2025 was $457000.0 at Pacific Biosciences Of California, up from -$2.7 billion in the prior quarter.
  • Over the last five years, Retained Earnings for PACB hit a ceiling of $457000.0 in Q4 2025 and a floor of -$2.7 billion in Q3 2025.
  • Median Retained Earnings over the past 5 years was -$1.3 billion (2022), compared with a mean of -$1.1 billion.
  • Biggest five-year swings in Retained Earnings: crashed 22849650.0% in 2022 and later soared 100.02% in 2024.
  • Pacific Biosciences Of California's Retained Earnings stood at -$1.2 billion in 2021, then skyrocketed by 99.61% to -$4.8 million in 2022, then tumbled by 38495.49% to -$1.8 billion in 2023, then soared by 100.02% to $422000.0 in 2024, then grew by 8.29% to $457000.0 in 2025.
  • The last three reported values for Retained Earnings were $457000.0 (Q4 2025), -$2.7 billion (Q3 2025), and -$2.6 billion (Q2 2025) per Business Quant data.